Patient Leaflet Updated 28-Mar-2025 | Neurocrine (formerly Diurnal)
Efmody 5 mg and 10mg modified release hard capsules
Efmody 5 mg modified-release hard capsules
Efmody 10 mg modified-release hard capsules
hydrocortisone
1. What Efmody is and what it is used for
2. What you need to know before you take Efmody
3. How to take Efmody
4. Possible side effects
5. How to store Efmody
6. Contents of the pack and other information
Medicine contains the active substance hydrocortisone. Hydrocortisone belongs to a group of medicines known as corticosteroids.
Hydrocortisone is a copy of the hormone cortisol. Cortisol is made by the adrenal glands in the body. Efmody is used when the adrenal gland are not making enough cortisol due to an inherited condition called congenital adrenal hyperplasia. It is for use in adults and adolescents from 12 years of age.
Talk to your doctor or pharmacist before taking Efmody if the following apply:
Adrenal crisis
Infections
Immunisation
Fertility
Other
You should not stop taking Efmody without checking with your doctor as this could make you seriously unwell very quickly.
As Efmody is replacing the normal hormone your body lacks, side effects are less likely, however:
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Some medicines can affect the way that Efmody works and may mean that your doctor needs to alter your dose of Efmody.
Your doctor may need to increase your dose of Efmody if you take certain medicines, including:
Your doctor may need to decrease your dose of Efmody if you take certain medicines including:
If you are taking medicines that can lower your potassium levels, your risk of developing hypokalaemia (low potassium) will be higher than when taking Efmody alone and will be monitored by your doctor. These medicines include:
Some food and drink may affect the way Efmody works and may need your doctor to decrease your dose. These include:
Hydrocortisone is known to cross the placenta in pregnancy and is present in breast milk, however there is no evidence this causes any harm to the infant. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
If you are a woman who has not gone through menopause your periods might return or become more regular. The restored fertility may lead to unexpected pregnancy even before the reoccurrence of menstrual bleeding. See also section “Warnings and Precautions” regarding fertility in both men and women.
Efmody has minor influence on the ability to drive and use machines. Untreated adrenal insufficiency may affect the ability to drive and use machines. Tell your doctor immediately if you feel tired or dizzy when taking Efmody.
Always use this medicine exactly as your doctor, nurse or pharmacist has told you. Check with them if you are not sure.
Your doctor will decide on the right starting dose of Efmody and then adjust the dose as needed depending on the severity of your disease, how well you respond to Efmody and any changes in your condition, using blood tests to measure the effect on your adrenal gland and also to check your sodium and potassium levels. During illnesses, around the time of surgery and during times of serious stress, your doctor may ask you to take another corticosteroid medicine instead of, or as well as, Efmody.
The initial daily dose may be divided into 2 doses with two thirds to three quarters of your daily dose in the evening at bedtime and the rest given in the morning.
The morning dose of hydrocortisone modified-release hard capsules should be taken on an empty stomach at least 1 hour before a meal and the evening dose taken at bedtime at least 2 hours after the last meal of the day.
No information on the safety and efficacy of Efmody in children under 12 years is available. Other hydrocortisone containing medicines are available for children under 12 years.
Swallow the capsules with water .
Do not chew the capsules as it could change the release of the medicine.
If you take more Efmody than you should, contact your doctor or pharmacist for further advice as soon as possible.
If you forget to take a dose, take the dose as soon as possible.
Do not stop taking Efmody without asking your doctor first. Stopping the medicine suddenly could quickly lead to an adrenal crisis.
Tell your doctor or pharmacist if you become ill, suffer severe stress, get injured or are about to have surgery because your doctor may advise that you take another corticosteroid medicine instead of, or as well as, Efmody (see section 2).
Poisoning or death are rare with too much Efmody, but you should inform your doctor immediately.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very Common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Long-term treatment with hydrocortisone may reduce bone density. Your doctor will monitor your bones (see section 2).
People who require treatment with steroids may have a higher risk of heart disease. Your doctor will monitor you for this.
Long term treatment with hydrocortisone can affect growth in children and young people. Your doctor will monitor your growth in young people. Some children with congenital adrenal hyperplasia treated with hydrocortisone can have an earlier puberty than expected. Your doctor will monitor your development (see section 2).
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and carton after EXP. The expiry date refers to the last day of that month.
This medicine does not have any special temperature storage requirements.
Store in the original package.
Keep the bottle tightly closed in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Capsule
The capsule is made from gelatin.
Efmody 5 mg modified-release hard capsules (white/blue)
Titanium dioxide (E171) and indigotine (E132)
Efmody 10 mg modified-release hard capsules (white/green)
Titanium dioxide (E171), indigotine (E132) and yellow iron oxide (E172)
Printing ink
The printing ink on the capsules contains shellac, black iron oxide (E172), propylene glycol and potassium hydroxide
Efmody comes in a high density polyethylene bottles with child resistant, tamper-evident polypropylene screw cap with integrated desiccant. Each bottle contains 50 modified-release hard capsules.
Pack size:
Carton containing 1 bottle of 50 modified-release hard capsules.
Carton containing 2 bottles of 50 modified-release hard capsules (100 capsules).
Not all pack sizes may be marketed.
This leaflet was last revised in
UK Great Britain /Northern Ireland: 01/2025
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Cardiff Medicentre, Health Park, Cardiff, Wales, CF14 4UJ, UK
+44 2920 682 069
+44 (0)29 20 682069
www.neurocrine.com/uk